Biologic De-escalation Common and Works for Some Patients

A large study of biologics de-escalation in patients with CD shows that the practice is common and apparently ...

APRIL 7, 2025

Miguel Regueiro, MD, Picks His Favorite IBD Research From ACG 2024

Miguel Regueiro, MD, sat down with GEN to talk about some of his favorite studies focused on treating IBD.

NOVEMBER 19, 2024

Upadacitinib Versus Tofacitinib in UC; Etrasimod for Proctitis

Prospective studies that directly compare the efficacy of two different medications remain rare in our field, ...

NOVEMBER 15, 2024

New Consensus Statements Aim to Guide IBD Management Around Pregnancy

Helping patients with inflammatory bowel disease navigate pregnancy and breastfeeding can be a daunting task for ...

OCTOBER 25, 2024

Head-to-Head IL Inhibitors, SPICY Trial Surgical Techniques in CD

In this edition of The Regueiro Report, I highlight a head-to-head comparison of two drugs and another study ...

OCTOBER 16, 2024

The ABCs of Optimizing Drug Sequencing for IBD

The number of inflammatory bowel disease treatment options with different mechanisms of action has exploded over ...

OCTOBER 13, 2024

A Miss for FMT in Ulcerative Colitis, Additional Upadacitinib Benefits in Crohn’s

This month’s report looks at two distinct issues: fecal microbiota transplantation and upadacitinib.

SEPTEMBER 17, 2024

FDA Approves Guselkumab for UC

The FDA has approved guselkumab (Tremfya, Janssen) for patients with moderately to severely active ulcerative ...

SEPTEMBER 12, 2024

Guselkumab Shows Promise In Crohn’s Disease Trials

Guselkumab induced higher levels of clinical and endoscopic remission than placebo and ustekinumab in the GALAXI ...

AUGUST 23, 2024

Good News for Maintenance Therapies in IBD

Both studies in this month’s The Regueiro Report are about interleukin inhibitors: risankizumab and ...

JULY 16, 2024

Subcutaneous Infliximab or Vedolizumab For Maintenance Therapy in IBD; Fast-Acting Upadacitinib in Crohn’s

In this month’s The Regueiro Report, I highlight two studies on medications to treat inflammatory bowel ...

JUNE 19, 2024

The Time Is Right to Study Microbiome in IBD Therapy

Fecal microbiota transplants that alter the gut microbiome could bring relief to people with IBD who do not respond ...

JUNE 18, 2024